192 related articles for article (PubMed ID: 34555970)
1. [MHT: How and how long in healthy women above 65?].
Wiegratz I
Ther Umsch; 2021; 78(8):457-464. PubMed ID: 34555970
[TBL] [Abstract][Full Text] [Related]
2. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
3. [Menopause hormone treatment in practice. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Gosset A; Robin G; Letombe B; Pouillès JM; Trémollieres F
Gynecol Obstet Fertil Senol; 2021 May; 49(5):358-372. PubMed ID: 33757922
[TBL] [Abstract][Full Text] [Related]
4. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
[TBL] [Abstract][Full Text] [Related]
5. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
6. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Hugon-Rodin J; Perol S; Plu-Bureau G
Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
[TBL] [Abstract][Full Text] [Related]
7. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
Gu Y; Han F; Xue M; Wang M; Huang Y
BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
[TBL] [Abstract][Full Text] [Related]
8. Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review.
Sobel TH; Shen W
Menopause; 2022 Jan; 29(4):483-490. PubMed ID: 35357370
[TBL] [Abstract][Full Text] [Related]
9. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper.
Genazzani AR; Divakar H; Khadilkar SS; Monteleone P; Evangelisti B; Galal AF; Priego PIR; Simoncini T; Giannini A; Goba G; Benedetto C
Int J Gynaecol Obstet; 2024 Feb; 164(2):516-530. PubMed ID: 38178609
[TBL] [Abstract][Full Text] [Related]
10. Menopause hormone treatment after cancer.
Gompel A
Climacteric; 2023 Jun; 26(3):240-247. PubMed ID: 37011657
[TBL] [Abstract][Full Text] [Related]
11. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
[TBL] [Abstract][Full Text] [Related]
12. Hormone Therapy: Menopausal Hormone Therapy.
Eubanks A
FP Essent; 2023 Aug; 531():15-21. PubMed ID: 37603881
[TBL] [Abstract][Full Text] [Related]
13. The impact of menopausal hormone therapy on overall mortality - a comprehensive review.
Stute P; Stadler A; Heufelder A
Climacteric; 2020 Oct; 23(5):447-459. PubMed ID: 32552066
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg S; Al-Daghri N; Aubertin-Leheudre M; Brandi ML; Cano A; Collins P; Cooper C; Genazzani AR; Hillard T; Kanis JA; Kaufman JM; Lambrinoudaki I; Laslop A; McCloskey E; Palacios S; Prieto-Alhambra D; Reginster JY; Rizzoli R; Rosano G; Trémollieres F; Harvey NC
Osteoporos Int; 2020 Dec; 31(12):2271-2286. PubMed ID: 32642851
[TBL] [Abstract][Full Text] [Related]
15. Prescribing menopausal hormone therapy: an evidence-based approach.
Sood R; Faubion SS; Kuhle CL; Thielen JM; Shuster LT
Int J Womens Health; 2014; 6():47-57. PubMed ID: 24474847
[TBL] [Abstract][Full Text] [Related]
16. What the Women's Health Initiative has taught us about menopausal hormone therapy.
Chester RC; Kling JM; Manson JE
Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
[TBL] [Abstract][Full Text] [Related]
17. Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: analysis of the Korea National Health Insurance Service Database.
Kim JE; Choi J; Park J; Shin A; Choi NK; Choi JY
Menopause; 2021 Sep; 28(11):1225-1232. PubMed ID: 34520413
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and bones after menopause: a reappraisal of data and future perspectives.
Anagnostis P; Bosdou JK; Vaitsi K; Goulis DG; Lambrinoudaki I
Hormones (Athens); 2021 Mar; 20(1):13-21. PubMed ID: 32519298
[TBL] [Abstract][Full Text] [Related]
19. Menopausal Hormone Therapy: a Comprehensive Review.
Lundberg G; Wu P; Wenger N
Curr Atheroscler Rep; 2020 Jun; 22(8):33. PubMed ID: 32556827
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
